Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| USANA HEALTH SCIENCES INCUSNA · Entity 6114 | CHIEF PEOPLE OFFICER | June 08, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
USANA HEALTH SCIENCES INC
Report date June 08, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-08 transaction · row 1
1 source rowRow 1 · 2026-06-08 · Sale · Disposed 5,561 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2020 Filed Feb 6, 2020 02:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock units · Derivative | 3,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-001223 · edgar.xml · derivative · entry 4 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,968 Underlying: Common Stock · 3,823 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F5 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. F5 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 3rd, 2020. Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 21:04 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 549 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-011238 · edgar.xml · derivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,145 Underlying: Common Stock · 549 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: On October 23rd, 2017, the reporting person was granted 2,198 restricted stock units, vesting at 25% on each 23rd of October thereafter. F2 · derivative.expiration_date: On October 23rd, 2017, the reporting person was granted 2,198 restricted stock units, vesting at 25% on each 23rd of October thereafter. Read SEC document |
| October 23, 2019 Filed Oct 25, 2019 21:04 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 549 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-011238 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 23:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units · Derivative | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · derivative · entry 5 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,694 Underlying: Common Stock · 1,215 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 23:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Tax withholdingRestricted Stock Units | 394 | $117.19 | $46,172.86 |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · nonDerivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,371 Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 23:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionRestricted Stock Units | 1,215 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 1,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · derivative · entry 4 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,909 Underlying: Common Stock · 1,371 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:21 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock units · Derivative | 4,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · derivative · entry 3 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,538 Underlying: Common Stock · 4,031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 22:40 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 550 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-012348 · edgar.xml · derivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,507 Underlying: Common Stock · 550 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: On October 23rd, 2017, the reporting person was granted 2,198 restricted stock units, vesting at 25% on each 23rd of October thereafter. F2 · derivative.expiration_date: On October 23rd, 2017, the reporting person was granted 2,198 restricted stock units, vesting at 25% on each 23rd of October thereafter. Read SEC document |
| October 23, 2018 Filed Oct 25, 2018 22:40 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-18-012348 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 14,000 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-18-004087 · edgar.xml · derivative · entry 3 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 10,696 | $81.00 | $866,376.00 |
DisclosureSEC source: 0001179110-18-004087 · edgar.xml · nonDerivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 22:31 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 10,696 | $19.12 | $204,454.04 |
DisclosureSEC source: 0001179110-18-004087 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 22:39 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 4,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-18-001746 · edgar.xml · derivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,057 Underlying: Common Stock · 4,859 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:42 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | GrantRestricted Stock Units · Derivative | 2,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-013433 · edgar.xml · derivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,198 Underlying: Common Stock · 2,198 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of October 23rd, 2017. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 877 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · derivative · entry 9 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 877 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 618 | $64.50 | $39,861.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 6 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 01, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 618 | $19.12 | $11,813.07 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 5 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 4,567 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · derivative · entry 8 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,877 Underlying: Common Stock · 4,567 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 3,213 | $64.50 | $207,238.50 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 4 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 3,213 | $19.12 | $61,416.50 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 3 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionStock Settled Stock Appreciation Rights · Derivative | 8,556 | $0.00 Strike: $19.12 | $0.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · derivative · entry 7 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,444 Underlying: Common Stock · 8,556 shares Expires 2018-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | SaleCommon Stock | 6,020 | $64.50 | $388,290.00 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 2 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:55 UTC | USANA HEALTH SCIENCES INC USNA · Entity 6114 | Exercise / conversionCommon Stock | 6,020 | $19.12 | $115,072.30 |
DisclosureSEC source: 0001179110-17-008291 · edgar.xml · nonDerivative · entry 1 Jones Paul A. · CIK 0001565541 · Chief Leadership Devlop Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,020 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares acquired resulted from reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table-II Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.